What is the BMRN stock price prediction for next 2 weeks?

According to our price prediction algorithm,BioMarin Pharmaceutical Inc. (BMRN) price will be around $55.96 in the next 2 weeks. This means it will decrease by -8.07950065703023 from the last closing price. This prediction may vary from other time period filters for BMRN stock.

What can be the highest Possible price of BMRN stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, BMRN can achieve the highest price of $57.51 which is -5.531841700780947 lower than last closing price. This prediction may vary from other time period filters for BMRN stock.

What can be the lowest Possible price of BMRN stock in next 2 weeks?

As per the forecast and algorithmic analysis, BMRN stock price can be as low as $54.56 which is -10.385442526198911 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for BMRN stock.

Will BMRN stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that BMRN stock will lose-8.07950065703023 in the next 2 weeks. This prediction may vary from other time period filters for BMRN stock.

What is BMRN stock last closing price?

Last closing price of BMRN stock was $60.88.

What is BMRN stock price prediction?

BMRN stock price prediction means predicting the future closing prices of BMRN stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of BMRN stock in a certain time period.

How we predict BMRN stock future prices?

If you are searching for BMRN stock forecast, analysis or price prediction, then you might be wondering what BioMarin Pharmaceutical Inc. (BMRN) will do in the future. Our BMRN price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This BMRN price prediction will likely answer most of your questions.

How frequent we update BMRN stock predictions?

We are updating the forecasts for the BMRN stock on daily basis.

Is using ML forecasting for BMRN stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for BMRN stock same for all the time periods?

No, the prediction for BMRN stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

BioMarin Pharmaceutical Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$60.88-2.78%Since 2 Weeks

Predicted Price$55.96-8.08%For 2 Weeks

Upper Predicted Price$57.51-5.53%For 2 Weeks

Lower Predicted Price$54.56-10.39%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of BMRN will decline by -8.08% over the next 2 Weeks and hit $55.96 by Monday, March 23, 2026. In that time frame, BMRN's share price is expected to range between $54.56 and $57.51.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Mar 23, 2026	54.56	55.96	57.51
Mar 20, 2026	55.63	56.92	58.32
Mar 19, 2026	56.23	57.39	58.57
Mar 18, 2026	56.76	57.81	58.93
Mar 17, 2026	56.72	57.71	58.67
Mar 16, 2026	57.32	58.24	59.19
Mar 13, 2026	58.24	59.20	60.09
Mar 12, 2026	58.74	59.67	60.55
Mar 11, 2026	59.23	60.09	60.95
Mar 10, 2026	59.10	59.99	60.86

BMRN shares rose +0.34% in Tuesday, March 10, 2026's trading session, rising from a previous close of $60.88 to move at $61.09. The stock demonstrated notable intraday movement (see BMRN's key stats for a full breakdown), fluctuating between $60.60 and $61.49, a +1.47% trading range. While recent weeks have seen some volatility, BMRN has managed to secure a -4.67% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 1.3M shares changing hands, 1.33M fewer than the previous session. This amounted to $79.47M in total market activity.

Will BMRN Continue Its Downward Trend?

According to analyst ratings and projections for BMRN, BioMarin Pharmaceutical Inc. shares are anticipated to decrease by -6.22%, potentially reaching $57.51 per share by March 23, 2026. Short-term technical indicators currently suggest a neutral sentiment for BMRN. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the BMRN stock forecast, now is not the best time to buy BMRN stock because its current trading price is +9.16% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on BMRN covering social and institutional perspectives.

BMRN Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into BMRN's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 53.33% to 54.78%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 53.76%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 51.41%, maintains a neutral outlook for the long term. Insights into BMRN's shareholder base show how institutional investors are positioning themselves during these momentum shifts

BioMarin Pharmaceutical Short-Term Forecasts

BMRN Forecast For Next 5 Days

Our algorithm anticipates BioMarin Pharmaceutical (BMRN) stock could hit $56.18 by Mar 17, 2026. This represents a -8.04% fall from today's price, following a -2.43% change over the past five days.

BMRN Forecast For Next 30 Days

Based on analysis of market trends, the outlook for BioMarin Pharmaceutical Inc. (BMRN) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $60.82, which would mean a -0.44% decrease from the current price of $61.09. Projections for this period range from a high of $66.10 to a low of $53.83.

BMRN Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for BioMarin Pharmaceutical's price over the next three months point to a drop. BMRN stock is expected to peak at $64.11 on May 04, 2026 before potentially dipping to $55.81 on Jun 10, 2026. On average, BMRN is likely to trade around $59.95 in the coming 90 days.

BioMarin Pharmaceutical Stock Forecast 2025

Based on our predictive models, BioMarin Pharmaceutical (BMRN) is expected to trade between $45.35 and $64.11 throughout 2026. This would result in an average price of $55.11, potentially offering investors a -9.79% return from current levels.

BioMarin Pharmaceutical Inc. Monthly Forecast 2026–2027

March 2026

According to our latest forecast models, BioMarin Pharmaceutical Inc. (BMRN) is positioned to show a strong performance in March 2026. The price is predicted to move between $57.64 and $63.64, settling at an average of $60.52. This could translate to a -0.93% loss.

April 2026

Based on current market signals, BioMarin Pharmaceutical Inc. is projected to trend april 2026. We forecast a trading range from $56.56 to $63.85, with a likely average price of $59.73. Investors could expect a potential return of -2.23%.

May 2026

Our predictive algorithms indicate BioMarin Pharmaceutical Inc. stock may see a shift in May 2026. The expected range spans $56.97–$64.11, with an average target of $60.11. This represents a cautious outlook and a possible loss of -1.60%.

June 2026

Analyzing established trends, BioMarin Pharmaceutical Inc. looks set to move in June 2026. Projections place the stock between $53.84 and $61.77, averaging around $57.69. This suggests a -5.57% loss from current levels.

July 2026

Market indicators suggest BioMarin Pharmaceutical Inc. could experience notable changes during July 2026. Prices could fluctuate within $52.77 to $59.23, with a midpoint forecast of $55.96. The stock might deliver a -8.40% loss.

August 2026

Forecasting for August 2026, models estimate that BioMarin Pharmaceutical Inc. may undergo key fluctuations. If trends hold, the stock might trade between $50.83 and $56.72, averaging $53.67. This signals a cautious trajectory with potential returns around -12.15%.

September 2026

According to our latest forecast models, BioMarin Pharmaceutical Inc. (BMRN) is positioned to show a strong performance in September 2026. The price is predicted to move between $49.61 and $57.23, settling at an average of $52.99. This could translate to a -13.26% loss.

October 2026

Based on current market signals, BioMarin Pharmaceutical Inc. is projected to trend october 2026. We forecast a trading range from $47.31 to $57.01, with a likely average price of $52.87. Investors could expect a potential return of -13.46%.

November 2026

Our predictive algorithms indicate BioMarin Pharmaceutical Inc. stock may see a shift in November 2026. The expected range spans $46.18–$54.46, with an average target of $50.29. This represents a cautious outlook and a possible loss of -17.68%.

December 2026

Analyzing established trends, BioMarin Pharmaceutical Inc. looks set to move in December 2026. Projections place the stock between $45.35 and $52.32, averaging around $48.96. This suggests a -19.86% loss from current levels.

January 2027

Market indicators suggest BioMarin Pharmaceutical Inc. could experience notable changes during January 2027. Prices could fluctuate within $43.82 to $49.71, with a midpoint forecast of $46.69. The stock might deliver a -23.57% loss.

February 2027

Forecasting for February 2027, models estimate that BioMarin Pharmaceutical Inc. may undergo key fluctuations. If trends hold, the stock might trade between $42.66 and $50.86, averaging $46.10. This signals a cautious trajectory with potential returns around -24.54%.

March 2027

According to our latest forecast models, BioMarin Pharmaceutical Inc. (BMRN) is positioned to show a strong performance in March 2027. The price is predicted to move between $43.64 and $49.81, settling at an average of $46.85. This could translate to a -23.31% loss.

BMRN's history of dividends and stock splits also plays a role in long-term investor confidence.